检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王洪巨[1] 康品方[1] 叶红伟[2] 于影[2] 王晓梅[2] 高琴[2,3]
机构地区:[1]蚌埠医学院第一附属医院心内科,安徽蚌埠233004 [2]蚌埠医学院生理学教研室 [3]安徽省组织移植重点实验室,安徽蚌埠233030
出 处:《南方医科大学学报》2012年第3期345-348,共4页Journal of Southern Medical University
基 金:国家自然科学基金(81000074);安徽省自然科学基金(090413097)~~
摘 要:目的观察乙醛脱氢酶2(ALDH2)在糖尿病大鼠心肌缺血/再灌注凋亡发生中的作用。方法大鼠分为正常组、糖尿病组和ALDH2激动剂乙醇+糖尿病组。4周后行离体心肌缺血/再灌注(I/R)。测定复灌期间冠脉流出液中乳酸脱氢酶(LDH)含量。检测心肌组织细胞ALDH2、caspase-3的活性;RT-PCR测定左心室前壁心尖组织Bcl-2、Bax mRNA的表达。结果与正常大鼠I/R相比,糖尿病大鼠复灌期冠脉流出液中LDH释放增加,心肌组织caspase-3活性增加,ALDH2活性降低,Bcl-2/Bax mRNA比值降低;与糖尿病大鼠心肌I/R相比,ALDH2激动剂乙醇使得心肌复灌期间冠脉流出液中LDH释放减少,心肌caspase-3活性降低,ALDH2活性增高,Bcl-2/Bax mRNA比值增高。结论增强ALDH2在糖尿病大鼠心肌中的表达对缺血/再灌注损伤有明显的保护作用;其机制可能与抑制细胞凋亡的发生有关。Objective To evaluate the anti-apoptotic effect of aldehyde dehydrogenase 2(ALDH2) on myocardial ischemia/reperfusion(I/R) injury in diabetic rats.Methods Normal male SD rats were divided into normal,diabetes and ethanol(the agonist of ALDH2) + diabetes groups.In the latter two groups,diabetes was induced by an intraperitoneal injection of 55 mg/kg STZ.Four weeks after the modeling,myocardial I/R was mimicked ex vivo,and lactate dehydrogenase(LDH) content in the coronary flow was determined.The activities of caspase-3 and ALDH2 were evaluated,and the expressions of Bcl-2 and Bax mRNA in the left anterior myocardium were detected using RT-PCR.Results In diabetic group,LDH release and caspase-3 activity were increased,while ALDH2 activity and Bcl-2/Bax mRNA expression were decreased as compared to those in normal control group.Compared with the diabetic group,ALDH2 agonist ethanol significantly reduced LDH release and caspase-3 activity,increased ALDH2 activity and Bcl-2/Bax mRNA expression.Conclusion In diabetic rats,enhanced ALDH2 expression can offer mycardial protection possibly in relation to suppress cell apoptosis.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.147